VERACYTE, M&A Monday, September 14, 2026 0.00 Neutral

Veracyte agrees to acquire Convergent Genomics

Veracyte, Inc. has entered into a definitive agreement and plan of merger with Convergent Genomics, Inc. that will result in the latter becoming a wholly-owned subsidiary following the transaction.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day